Avalo Therapeutics, Inc. - Common Stock (NQ:AVTX)
4.000
+0.090
(+2.30%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 19, 2025
Add to My Watchlist
All News about Avalo Therapeutics, Inc. - Common Stock

Why Mainz Biomed Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
September 13, 2023
Via Benzinga


Crude Oil Rises 2%; Avalo Therapeutics Shares Spike Higher
September 12, 2023
Via Benzinga
Topics
Stocks


12 Health Care Stocks Moving In Tuesday's Intraday Session
September 12, 2023
Via Benzinga

Dow Turns Higher; Oracle Shares Tumble After Q1 Results
September 12, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities

Why Microcap Biotech Firm Avalo Therapeutics Stock Is Trading Higher Today?
September 12, 2023
Via Benzinga

Dow Falls 75 Points; US Small Business Optimism Drops In August
September 12, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 12, 2023
Via Benzinga

Avalo Enters into Agreement to Divest AVTX-800 Series
September 12, 2023
From Avalo Therapeutics
Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's After-Market Session
September 07, 2023
Via Benzinga

From Avalo Therapeutics
Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Pre-Market Session
August 24, 2023
Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session
August 18, 2023
Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session
August 18, 2023
Via Benzinga






12 Health Care Stocks Moving In Thursday's After-Market Session
August 17, 2023
Via Benzinga








From Avalo Therapeutics
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free